AVA6000 is a novel form of doxorubicin that has been modified using Avacta’s delivery platform to improve safetyOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.